The complete DNA sequence of the Marek's disease virus serotype 1 vaccine strain CVI988 was determined and consists of 178 311 bp with an overall gene organization identical to that of the oncogenic strains. In examining open reading frames (ORFs), nine differ between vaccine and oncogenic strains. A 177 bp insertion was identified in the overlapping genes encoding the Meq, RLORF6 and 23 kDa proteins of CVI988. Three ORFs are predicted to encode truncated proteins. One, designated 49.1, overlaps the gene encoding the large tegument protein UL36 and encodes a severely truncated protein of 34 aa. The others, ORF5.5/ORF75.91 and ORF3.0/78.0, located in the repeat regions (diploid), encode a previously unidentified ORF of 52 aa and a truncated version of the virus-encoded chemokine (vIL-8), respectively. Subtle genetic changes were identified in the two ORFs encoding tegument proteins UL36 and UL49. Only one diploid ORF (ORF6.2/ORF75.6) present in the genomes of the three virulent strains is absent in the CVI988-BAC genome. Seventy non-synonymous amino acid substitutions were identified that could differentiate CVI988-BAC from all three oncogenic strains collectively. Estimates of the non-synonymous to synonymous substitution ratio (v) indicate that CVI988 ORFs are generally under purifying selection (v<1), whereas UL39, UL49, UL50, RLORF6 and RLORF7 (Meq) appear to evolve under relaxed selective constraints. No CVI988 ORF was found to be under positive evolutionary selection (v&1).
INTRODUCTION
Marek's disease (MD) is a highly contagious neoplastic and neuropathic disease of chickens responsible for great economic losses to the poultry industry (Calnek, 2001) . The causative agent of the disease is a mardivirus, Marek's disease virus (MDV-1), a member of the subfamily Alphaherpesvirinae in the family Herpesviridae. MDV is by far the most oncogenic herpesvirus known and represents the first of three neoplastic diseases (including hepatocellular carcinoma, caused by Hepatitis B virus, and cervical carcinoma, caused by Human papillomavirus) for which an effective vaccine has been developed (Churchill et al., 1969; Pagliusi & Teresa Aguado, 2004; Prince, 1996) . The disease is largely controlled through mass vaccination of chick embryos or day-old chicks with live-attenuated strains of MDV-1 (Witter, 2001b) . Since their introduction in the 1970s, MDV vaccines have reduced economic losses from MD dramatically, by more than 99 % (Witter, 2001a) . However, over the last 40 years of intense vaccination, virulent strains have reappeared, necessitating the continued introduction of new vaccines at fairly regular intervals (Witter, 1997) . In the 1970s, MD was controlled by a vaccine derived from herpesvirus of turkeys (HVT) (Witter et al., 1970) , only to be replaced in the 1980s with a bivalent vaccine consisting of SB-1 (serotype 2 MDV) and HVT (Schat & Calnek, 1978) . Since the 1990s, the disease has been largely controlled by vaccination with the attenuated serotype 1 strain CVI988 (Rispens et al., 1972) . Despite its global usage and exceptional protective efficacy, there are signs of further increases in MDV virulence, as shown by the isolation of strains with higher pathogenicity even in birds vaccinated with the CVI988 strain (Davison & Nair, 2005; Nair, 2005) . Because of this, there is great concern that CVI988-based vaccination programmes may eventually fail to protect poultry in the same way that previous generations of MD vaccines have lost their usefulness. The emergence of so-called breakthrough variants may have devastating effects on the poultry industry in the future.
In order to prevent this scenario, a better understanding of the genes involved in virulence is needed. Although many unique MDV genes, such as the viral lipase homologue (vLIP), virus-encoded telomerase RNA (vTR), pp38 and Meq, have been demonstrated to play a role in virulence or oncogenicity through studies on knockout mutants, it still remains to be determined whether vaccine strains have alterations in the genes encoding these factors or possibly in other genes (Fragnet et al., 2003; Gimeno et al., 2005; Kamil et al., 2005; Lupiani et al., 2004) . To this end, we have embarked on a comparative genome analysis of vaccine and oncogenic strains in the hope that it will provide some clue to the multigenic nature of MDV virulence and identify CVI988 ORFs that have evolved under positive Darwinian selection as a result of immune evasion.
The genome organization of linear MDV has been reviewed elsewhere (Osterrieder & Vautherot, 2004; Silva et al., 2001) . In this paper, we present the sequence of the full-length bacterial artificial chromosome (BAC) clone of the CVI988 genome, designated pCVI988-BAC (Petherbridge et al., 2003) . The genomic structure and gene content will be compared with those of three oncogenic strains of MDV: GA, Md5 and Md11 (Lee et al., 2000a; Niikura et al., 2006; Tulman et al., 2000) .
METHODS
Construction of pCVI988. The construction of pCVI988-BAC was carried out essentially as described previously by the insertion of the F plasmid into the US2 gene (Petherbridge et al., 2003) . Briefly, CVI988 genomic DNA and pDS-pHA1 were cotransfected into secondary chicken embryo fibroblasts by the calcium phosphate precipitation procedure. After selection in medium containing mycophenolic acid, xanthine and hypoxanthine, genomic DNA from infected cells was electroporated into Escherichia coli (DH10B) cells (Invitrogen) and plated onto agar dishes containing chloramphenicol.
DNA sequencing. DNA from E. coli DH10B cells harbouring pCVI988-BAC was isolated by Midiprep alkaline lysis according to the manufacturer's instruction (Qiagen). Sequencing of pCVI988-BAC was initially carried out commercially. This involved the construction of a random shotgun library of pCVI988-BAC DNA in the pGEM-T vector (Promega) and sequencing of sufficient clones to obtain a sixfold coverage of the genome. To obtain the sequence of the US region of the CVI988 genome replaced by the pDS-PHA1 vector, the corresponding region was amplified by PCR using Pfu DNA polymerase (Promega) and wild-type CVI988 DNA. PCR products from the pCVI988-BAC DNA were also used for gap closure of the initial contigs using primers derived from the sequence. DNA sequence data were obtained from recombinant plasmids by using BigDye Terminator cycle sequencing and a model ABI-3730 XL DNA Analyzer (Applied Biosystems). Problematic regions were sequenced from clones containing inserts generated by PCR using Platinum Taq DNA polymerase (Invitrogen) and numerous custom primers. Regions in the genome containing highly repetitive elements (a-like sequences) were sequenced from clones by using random transposon-mediated mutagenesis (Epicentre Technologies) and transposon-specific primers. The diverse regions of the UL36 and UL48 genes were sequenced from PCR products generated in amplification reactions containing whole-genome DNA isolated from two additional CVI988 strains, Intervet p27 and ADOL BP5.
Copy-number determination of a-like sequences. Anchor PCR and restriction analysis were used to determine the number of a-like sequences within the IRL/IRS and TRS/TRL junctions. Amplification reactions contained 100 ng pCVI988-BAC, a primer specific for repeat short sequences that flanked the a-like sequence and a primer specific for either the 59 or 39 end of the unique long sequence (Fig. 1) . PCR products (~16 kb) were digested with SmaI and resolved on 16 TAE agarose gels.
DNA sequence analysis. DNA sequences were assembled by using the Sequencher program (Gene Codes) and edited manually. The final sequence represents, on average, a sixfold redundancy at each base pair. Open reading frames (ORFs) and DNA regulatory sequences were identified by using various software packages that included DNASTAR, GeneMarkS (GeneProbe) (Besemer & Borodovsky, 2005) , NCBI Entrez and other web-based tools. Novel ORFs were identified based on codon usage and investigated by using Spin (Staden) and CUSP (EMBOSS) programs (Staden et al., 
2000)
. Homology searches were conducted by using the NCBI programs BLAST (BLASTP) and PSI-BLAST (Schaffer et al., 2001 ) with default settings, as well as Pairwise FLAG (BMEC/ITRI). Published mRNA and cDNA data were compared with the CVI988 genome by using PROT_MAP (SoftBerry). Multiple protein sequences were aligned by using MultAlin, CLUSTAL_W and MAFFT (Corpet, 1988; Katoh et al., 2005) . Repeat elements were investigated by using the Tandyman program (Los Alamos National Laboratory, NM, USA). Phylogenetic trees were constructed by using MAFFT and MEGA version 3 (Kumar et al., 2004) with full-length genomic sequences corresponding to the available Md11 sequencing data. Evolutionary adaptation estimations based on synonymous and non-synonymous substitutions were calculated by using a model that includes allelic mixtures and the Jukes-Cantor correction for back mutations (Syn-SCAN) (Gonzales et al., 2002; Jukes & Cantor, 1969) .
RESULTS AND DISCUSSION

Genomic organization
The CVI988-BAC genome (GenBank accession no. DQ530348) was found to have a G+C content of 44 mol% and a length of 178 311 bp, a size similar to those of the other sequenced strains: Md5 (177 kb), Md11 (178 kb) and GA (174 kb). The genome is organized into six regions characteristic of class E alphaherpesviruses. The unique long (UL) region is 113 490 bp in length and extends from positions 14 477 to 127 966. The short (US) region is 11 651 bp in length and extends from positions 154 606 to 166 256. In order to determine the length of the repeat regions (TRL, IRL, IRS and TRS), the nucleotide sequences and copy numbers of the adjacent a-like sequences needed to be determined. PCR primers (flanking the a-like sequences) were designed based on multiple alignments of the published genomic sequences, and used in amplification reactions. It was hypothesized that two copies of the a-like sequence would be present at the TRS/TRL junction in the circular CVI988-BAC construct, as the linear form of MDV contains a-like sequences at both termini. Surprisingly, only a single PCR product of 2.3 kb was generated, suggesting that only one copy of the a-like sequence was present within both the IRL/IRS and TRS/TRL junctions. To confirm this, additional PCR experiments involving anchor PCR and restriction-endonuclease analysis were implemented. As shown in Fig. 1 , large PCR products with the predicted sizes of 16.1 and 16.2 kb were produced with primers specific for the IRL and TRL regions, respectively. A SmaI restriction digestion of these products generated a nearly identical restriction profile. Differences were only noticeable for the bands (C) that contained unique long and repeat long sequences. The B bands, which contained the a-like sequences, were the same size for both digestions. These results and the inability to generate PCR products containing two a-like copies indicated that only one copy was present at the IRL/IRS and TRS/TRL junctions. Single copies of the a-like sequence within these junctions have also been reported for the Md11-BAC construct (Niikura et al., 2006) .
As it is impossible to determine the boundaries of the a-like sequence in a circular construct containing only one copy at each junction, the combined lengths of the internal repeat regions (long and short) of CVI988-BAC, including the alike sequences, are 26 639 bp. The lengths of the terminal long (TRL) and short (TRS) repeats (14 476 and 12 055 bp, respectively) were determined based on the assumption that cleavage of concatameric replicative intermediates occurs within telomeric repeats bracketed by pac1 and pac2 sites.
In comparison to other MDV isolates, the genomic regions of CVI988-BAC are most similar to those of Md11. Overall, the sizes of the unique regions (UL and US) were comparable among all of the strains. Size differences among the genomes can be attributed to the junctions between the unique short and the repeat short regions, as well as tandem reiterations found in the repeat long regions. An evolutionary tree of the four strains of MDV-1 is presented in Fig. 2 , based on the nucleotide alignment of the TRL, UL, IRL, IRS regions and part of the US region, and illustrates that both CVI988 and GA are related more distantly to a common ancestor than are Md5 and Md11. Fig. 2 . Unrooted phylogenetic tree of genomes of MDV-1 strains CVI988, Md5, Md11 and GA based on the genomic segments TRL, UL, IRL and IRS and partial US sequences. Alignments were made by using the MAFFT program and a dendrogram was drawn by using MEGA3 programs.
ORFs
The genome of CVI988-BAC contains over 478 ORFs encoding proteins with ¢50 aa. Those of significance for a genomic comparison between pathotypes are presented in Table 1 and are numbered according to the decimal system (Tulman et al., 2000) . Novel ORFs, predicted based on the codon usage of well-characterized mardivirus genes, were named according to their first 4 aa (Table 1b) . A homology comparison of each ORF from the four strains is also presented in Table 1 , along with the putative functions of many of these ORFs based on protein binding partners and similarities to homologues belonging to other alphaherpesviruses (Niikura et al., 2004; Nishiyama, 2004) . Overall, identity is typically >98 % at the amino acid level for nonnovel ORFs (Table 1a) . Because of frameshift mutations, a large number of genes (LORF11, RLORF1, UL6, UL7, UL12, UL15, UL16, UL17, UL18, UL19, UL24, UL26, UL29, UL37 and UL52) within the GA genome have a lower degree of identity than homologues found in other mardiviral genomes.
Single-nucleotide polymorphisms (SNPs)
In order to identify amino acid changes important in attenuation, the nucleotide sequence of CVI988-BAC was compared with sequences from the oncogenic strains (Md5, Md11 and GA) by using the web-based programs MultAlin and MAFFT. As illustrated in Supplementary Fig. S1 (available in JGV Online), SNPs are present in ORFs throughout the genomes of MDV-1. Relative to CVI988, 109 and 99 non-synonymous substitutions were found in the ORFs of Md11 and Md5, respectively. Nearly three times as many non-synonymous substitutions, a total of 258, were found in the ORFs of strain GA. This number does not include the substitutions due to the 23 frameshift mutations (or possibly sequencing errors) found in 17 ORFs within the genome of GA. Most of the substitutions (n=188) were exclusive to strain GA and were not shared with either Md11 or Md5. Only 15 non-synonymous substitutions were exclusive to Md11 ORFs and five were exclusive to Md5 ORFs. Twenty-four of these substitutions were common to both Md11 and Md5 strains. The rest (n=70) were common to all three strains and could differentiate CVI988-BAC from the oncogenic strains of MDV (Table 2 ). These mutations were exclusive to CVI988 and corresponding substitutions were identical in all three of the virulent strains.
SNPs within coding regions without amino acid changes (i.e. synonymous substitutions) were also found among the strains, although the differences were not as dramatic as those noted for non-synonymous substitutions. The genes of Md11, Md5 and GA contain 54, 50 and 86 synonymous substitutions, respectively. The elevated level of nonsynonymous and synonymous substitutions as well as frameshift mutations largely contributed to the phylogenetic partitioning of the GA strain (Fig. 2) . To investigate this further and to determine whether evolutionary pressures are acting upon individual ORFs, the non-synonymous to synonymous substitution ratio (v=d N /d S ) was determined for ORFs containing non-synonymous mutations (see Supplementary Table S1 in JGV Online). Most of the genes examined had a mean v score of <1.0, indicating purifying (negative) selection or conservation of functional amino acids. For example, the UL49.5 gene in the CVI988 genome, encoding a 95 aa protein, is under strong selection for the synonymous mutations Ile 6 , Val 10 and Thr 36 , with a v score of 0.10. If GA ORFs that contain frameshift mutations are disregarded (e.g. LORF11, UL26, 29, 37 and 52), then only two genes, UL50 (dUTPase) and RLORF7 (Meq), can be considered to have neutral evolution, with mean v scores of >0.95. Interestingly, UL49.5 has been implicated in the repression of major histocompatibility complex (MHC) class I presentation by inhibiting TAP, and both dUTPase and Meq have been demonstrated to encode virulence factors in studies involving knockout mutants (Jons et al., 1997; Koppers-Lalic et al., 2005; Lipinska et al., 2006; Lupiani et al., 2004; Tischer et al., 2002) . With our limited dataset, no ORF was discovered to be under positive selection, i.e. with a d N /d S ratio&1.0.
Differences in ORFs within the unique regions
Most CVI988-BAC ORFs from the unique regions were found to be virtually identical (>98 % amino acid identity) to homologous ORFs from other MDV-1 strains. These genes are generally most similar to those in the genomes of Md5 and Md11 and show a reduced level of homology to those of the GA strain. Based largely on its size, the majority (>85 %) of non-synonymous amino acid substitutions occur within ORFs mapping to the unique long region and occur frequently within ORFs encoding structural proteins, mainly tegument proteins. ORF49 (UL36), which encodes the large tegument protein (McNabb & Courtney, 1992 ) of CVI988-BAC, is particularly interesting due to the fact that it contains small deletions and the largest number of nucleotide polymorphisms. Its herpes simplex virus type 1 (HSV-1) orthologue has been shown to be involved in protein-protein interactions with other tegument proteins (Klupp et al., 2002; Vittone et al., 2005) and, recently, a ubiquitin (Ub)-specific cysteine protease function has been mapped to the hightly conserved amino terminus of both HSV-1 and MDV-1 orthologues Schlieker et al., 2005) . Most of the non-synonymous substitutions in UL36 of MDV-1, however, occur in the carboxyl terminus, which is extremely heterogeneous both between isolates of MDV-1 and within other members of the subfamily Alphaherpesvirinae (Gomi et al., 2002) . As shown in Fig. 4 , we have determined the sequence of this region for two additional isolates of the vaccine strain CVI988 and, in comparison to CVI988-BAC and other strains, have found this region to contain reiterations of two sequences: KPPPPDPDFKS/TPAPKP and KPPPA/TPDSKPSPAPKP. Similar reiterations of proline-rich motifs have been found to be important in protein-protein interactions via SH3, WW and EHV1 domains (Kay et al., 2000; Zarrinpar et al., 2003) .
Overlapping the UL36 gene, one previously uncharacterized gene (ORF49.1) was discovered via an extensive computer analysis to determine the ORFs capable of encoding proteins (¢50 aa) that are present in the genomes of oncogenic strains, but absent in the CVI988-BAC genome. In the genomes of the oncogenic strains, ORF49.1 encodes a protein of 93 aa (Md5 and Md11) or 94 aa (GA), but in the genome of CVI988-BAC, a truncated protein of 34 aa is predicted, due to a point mutation. It is important to note that this is a silent mutation with respect to the UL36 ORF.
Comparative genomic studies with other MDV strains have indicated that the genomes of the CVI988 vaccine strains from Intervet (p27) and ADOL (BP5) also encode the 34 aa derivative, whereas virulent strains RB1B, JM/102W, 549a, 571, 584a, 595, 648a and 686, representing the virulent pathotypes, encode the full-length protein (unpublished results). A BLAST search for proteins similar to ORF49.1 failed to generate any believable hits. The role of this ORF in the pathogenesis of MDV remains unknown and will require additional investigation.
Another gene within the unique long region that differs among attenuated and oncogenic strains is UL49 (ORF62). This gene encodes the tegument protein VP22 and has been shown to be indispensable for virus propagation in cell culture (Dorange et al., 2000 (Dorange et al., , 2002 . A short deletion of 18 bp was found in this gene within the CVI988-BAC genome. This deletion corresponds to a domain that is rich in serine and threonine residues in the oncogenic homologues. Close inspection of the multiple alignment (Fig. 3 ) suggests a domain deletion (KSERT). In addition to CVI988-BAC, this deletion was also found in other vaccine derivatives of CVI988 from Intervet (p27) and ADOL (BP5). There is little sequence resemblance between this region and corresponding regions in the VP22 homologues of HSV and varicella-zoster virus (VZV). However, like its HSV-1 counterpart, VP22 (MDV-1) is a phosphorylated protein with DNA-binding activity and displays similar functional properties: intracellular spreading and nuclear-targeted protein transporting (Blaho et al., 1994; Dorange et al., 2000; Elliott et al., 1999; Phelan et al., 1998) .
The genes within the unique short region of CVI988-BAC are unremarkable in a genomic comparison, with protein identities >98 % and few polymorphisms. Unlike Md5, which encodes two sorf2 proteins (ORF87 and ORF97) (Tulman et al., 2000) , CVI988-BAC is more similar to Md11 and GA and lacks ORF97. Overall, the gene organization in the US region of the four sequenced strains is almost identical, with the exception of ORF97 in the Md5 genome. What is remarkable is the lack of sequence conservation in the inverted-repeat regions, which flank the unique short region.
Differences in ORFs within the inverted-repeat regions
This region is by far the most interesting, well-characterized region in the MDV genome and many of its ORFs have been defined functionally (Lupiani et al., 2001; Osterrieder & Vautherot, 2004) . These ORFs are largely mardiviralspecific, some even serotype 1-specific, and homologues are not generally found in other members of the subfamily Alphaherpesvirinae. The protein products encoded by these ORFs include the oncoprotein MEQ (ORF5/ORF76) (Jones et al., 1992) , the 23 kDa protein (ORF4/ORF77) (Peng & Shirazi, 1996b ) and viral interleukin-8 (vIL-8; ORF3/ ORF78) (Liu et al., 1999; Parcells et al., 2001) .
Within the repeat long region, the ORFs of CVI988-BAC show a mean of 97.2, 94.5 and 91.7 % identity to those of Md5, Md11 and GA, respectively. This subdued level of similarity is largely due to proteins that are truncated or contain insertions, most notably the gene products of ORF4/ ORF77, ORF5/ORF76 and ORF5.1/ORF77.5, encoding the 23 kDa protein, MEQ and RLORF6, respectively (Jones et al., 1992; Lee et al., 2000a; Peng & Shirazi, 1996b) . As illustrated in Fig. 4 , the overlapping genes encoding the 23 kDa, MEQ and RLORF6 proteins of CVI988-BAC all contain 177 bp insertions. Other researchers have previously reported insertions in the Meq loci of CVI988 (Chang et al., 2002b; Lee et al., 2000b; Shamblin et al., 2004) . In the original paper by Lee et al. (2000b) , a 178 bp insertion within the coding region of Meq (CVI988), specifically in the proline-rich domain, was reported to result in a frameshift. Petherbridge et al. (2003) reported previously, and we confirm, that the genes encoding the MEQ proteins of CVI988-BAC contain insertions of only 177 bp that are in frame. This is also in agreement with research examining Meq mutations not only in CVI988, but also in other attenuated strains of MDV-1 (Chang et al., 2002a; Petherbridge et al., 2003; Shamblin et al., 2004) . The general conclusion is that most attenuated strains of MDV-1 contain in-frame insertions (59 aa) in the Meq ORF, the probable result of domain duplication (see boxed regions in Fig. 4) . One notable exception is the attenuated strain R2/ 23, in which an additional thymidine residue within the Meq locus causes a frameshift mutation (Spatz & Silva, 2007) . Interestingly, all of the insertion mutations within the Meq genes of attenuated strains occur in the same region, the proline-rich domain, which has been shown to be essential for the trans-activation of MEQ-responsive promoters (Liu & Kung, 2000; Qian et al., 1996) . This domain, however, when used by itself in trans-activation analysis, represses transcription and behaves as a dominant-negative mutant.
In comparing the trans-activation/repression abilities of MEQ variants from attenuated and virulent strains, Chang et al. (2002c) reported that those containing the duplicated proline-rich motifs (coined L-MEQ) exhibit a higher level of trans-repression than do MEQ variants containing the single proline-rich motif (S-MEQ) found in virulent strains.
In addition to insertional mutations in the Meq genes of CVI988-BAC, three point mutations were discovered at aa 71, 77 and 385 (Table 2 ). This places the sequence of CVI988-BAC in the IV allelic group described by Laurent et al. (2004) . Other strains of MDV-1 classified as virulent (e.g. BC-1, JM102, 567, 617A, 637, 571, 573) have been reported to contain mutations at either position 71 or 77 (Shamblin et al., 2004 Within the repeat long region of CVI988-BAC, three ORFs (ORF3/ORF78, ORF5.5/ORF75.91 and ORF74) encode truncated proteins relative to those encoded by the genomes of the three oncogenic strains. Because of an opal (TGA) mutation, 20 aa are missing in the putative proteins of ORF5.5/ORF75.91 (CVI988-BAC). An extensive homology search using BLAST programs provided few clues to the possible function of these proteins. The function of the ORF3/ORF78 gene products, however, is far more defined. These ORFs are spliced genes with similarity to genes encoding the CxC chemokine IL-8 and hence termed vIL-8. We have discovered that, in the CVI988-BAC genome, these ORFs encode a truncated version of vIL-8 that is 11 and 13 aa shorter than those of Md5 and Md11/GA, respectively. Although the function of the carboxyl-terminal residues in the mammalian IL-8 orthologue has been reported to be non-essential for neutrophil binding, little information is available about the function of these residues in vIL-8 or avian IL-8 (Kaiser et al., 1999) . In fact, avian IL-8 contains only 103 aa, thus to some extent resembling CVI988-BAC vIL-8. As vIL-8-null MDV-1 mutants have been reported to be mildly virulent and to have a lower incidence of tumour formation, truncated versions of vIL-8 may also contribute to an attenuated phenotype (Cortes & Cardona, 2004; Cui et al., 2004) .
One ORF (ORF74 or RLORF12) within the internal repeat long region is predicted to encode a truncated protein of 67 aa. Unexpectedly, its diploid counterpart (ORF7) within the terminal repeat long region encodes a protein of 115 aa. All sequenced oncogenic strains of MDV encode RLORF12 homologues containing 115 aa; however, we have found recently that some attenuated strains (i.e. RM-1, CVI988-BP5 and JM/102W) contain deletions within this ORF and encode similar truncated proteins (Spatz & Silva, 2007) . This could be significant, as these deletions occur at the origin of replication and may affect the binding of the DNAbinding proteins (UL9 and UL8.5) involved in replication, as well as other proteins demonstrated to bind the RLORF12 protein, such as the growth-related translationally controlled tumour protein (TCTP) (Niikura et al., 2004) .
Within the repeat long regions, only one pair of diploid ORFs (ORF6.2/ORF75.6) was absent in the CVI988 genome, due to a point mutation in the start codon. In virulent strains, these ORFs are predicted to encode short polypeptides of 66 aa. Because of their small size, no significant similarity was found to any protein in GenBank. Whether these genes actually encode proteins or represent exons of uncharacterized proteins remains to be determined. In support of the latter notion, splicing and alternative splicing have been shown to occur within this region, as evidenced by the spliced gene products vIL-8 (Liu et al., 1999) , 14 kDa A and 14 kDa B (Hong & Coussens, 1994) , as well as alternatively spliced gene products involving exons 2 and 3 of vIL-8 RNA designated Meq/vIL-8, RLORF5a/vIL-8 and RLORF4/vIL-8 (Anobile et al., 2006; Jarosinski & Schat, 2007; Peng & Shirazi, 1996a; Peng et al., 1995) . Given the complex transcription patterns and alternative splicing that occur in this region, it is quite possible that additional spliced gene products exist.
The repeat short regions of CVI988-BAC, like those of oncogenic strains, largely encode the major immediate-early protein ICP4 (Anderson et al., 1992) . Over 57 % of the repeat short regions are devoted to encoding this transactivator. These proteins are >98 % identical among strains and, although there are differences, especially with ICP4 (GA), no polymorphisms were discovered that could differentiate attenuated versus oncogenic strains collectively. Thirty-four substitutions (23 non-synonymous and 11 synonymous) were discovered in the ICP4 gene of the GA strain relative to CVI988. Only three and six substitutions were found in ICP4 of Md5 and Md11, respectively, again suggesting a close evolutionary relationship between CVI988 and these two strains. Whether these substitutions are significant for attenuation remains to be determined, particularly in light of research demonstrating that ICP4 of a vaccine strain of VZV (Oka) has a lower trans-activation capacity than its parental counterpart and this contributes to its attenuated phenotype (Cohrs et al., 2006; Gomi et al., 2002) . What can be hypothesized is that the trans-activation potential of these two alphaherpesviruses seems to play a role in attenuation. Therefore, as few mutations were noted between ICP4 proteins of Md5 and CVI988, it seems likely that the trans-repression capability of L-MEQ and not the ICP4 protein itself is important in attenuation of CVI988. It is interesting to note that, although MEQ is expressed predominantly in the latent state, it is also expressed early in lytic infection and is capable of repressing the transcription of the ICP4 promoter through direct binding as a MEQ homodimer (Jones et al., 1992; Levy et al., 2003) .
Conclusions
In recent years, the use of MDV BAC recombinants and overlapping cosmid constructs has been instrumental in determining the function of various genes in the pathogenesis of MD. Five genes (RLORF4, vLIP, vTR, vIL-8 and the Meq/23 kDa locus) have been demonstrated to encode virulence factors (Cui et al., 2005; Jarosinski et al., 2005; Kamil et al., 2005; Lupiani et al., 2004; Trapp et al., 2006) . Of these, our data support a role for the MEQ oncoprotein in the attenuation of CVI988. No genetic changes were found in the genes encoding RLORF4, lipase (vLIP) or telomerase (vTR) of CVI988 compared with those found in Md5, Md11 and GA. It is likely that additional ORFs contribute to the attenuated phenotype of CVI988. This study has identified eight ORFs [49, 49.1, 62 and the diploid ORFs: Meq, RLORF6, 23 kDa, 5.5/75.91 and 3/78 (vIL-8)] in the CVI988-BAC genome that differ (are expanded or truncated) from those in the oncogenic strains, as well as one ORF (6.2/75.6) that is exclusively present in the genomes of the virulent strains. Only a short deletion in the carboxyl terminal of vIL-8 (CVI988) was discovered, but its significance is doubtful, due to the fact that other isolates of CVI988 contain genes encoding full-length vIL-8. Seventy non-synonymous amino acid substitutions were identified within the CVI988-BAC ORFs. These mutations were exclusive to CVI988 and corresponding substitutions were identical in all of the three virulent strains. Most of these occurred in tegument proteins, especially UL36, and will be useful in future genotyping studies. The ratios of nonsynonymous to synonymous mutations were examined in order to understand the selective pressures acting on various ORFs. Only two genes (UL50 and RLORF7) had d N /d S ratios >0.95, indicating a lack of selective pressure to conserve functional amino acids. All other genes examined with variations in non-synonymous and synonymous substitutions were under purifying selection.
Future comparative genomic studies examining a larger number of avirulent or less virulent strains in order to identify positively selected genes will undoubtedly contribute to our overall understanding of the genes involved in virulence. This information will be essential to engineer novel MDV-1 vaccines capable of protecting chickens against continuously evolving very virulent plus (VV+) strains.
